Amgen is set to release its second-quarter earnings next month, and analysts are projecting modest single-digit growth in ...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of ...

The global gene therapy market is projected to grow at a significant CAGR of 20% from 2024 to 2029. This growth is driven by ...

Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the Donald Trump administration's policies. Health care stocks can often be a solid defensive play in an ...

Major indices closed higher on Wednesday as traders digested more bank earnings and another key inflation report.

Boston conference will explore strategic partnering, device innovation, and delivery solutions for emerging therapeutics.

Major indices were in the green earlier on Wednesday as traders digested more bank earnings and another key inflation report.

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

Trump has again threatened the multibillion-dollar pharmaceutical sector with high tariffs unless they move production to the U.S.

The global women’s health market size was US$ 31.1 billion in 2021. The global women’s health market is expected to grow to US$ 4.1 billion by 2030 by registering a compound annual growth rate (CAGR) ...

CWM LLC raised its stake in Amgen by 8% in Q1, buying 11,175 more shares worth nearly $47 million. Other institutional ...

William Blair analysts cut AbbVie’s FY2025 earnings estimate to $11.82 per share from $12.21, citing revised outlooks. Other ...